Medication info
Diroprozijung 5/80mg (Amlodipine Besylate, Valsartan)

Diroprozijung 5/80mg (Amlodipine Besylate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
28 tablets (14 tablets/Alu-Alu pack ×2)
Approval status
Active

MFDS item code 201400081 · Approved 2014.01.09 · Insurance code 658602910

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted before treatment with this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with Amlodipine or Valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted before treatment with this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. It should not be used in patients who are allergic to its components or in pregnant or breastfeeding women, as well as in patients with severe kidney or liver diseases. Caution should be exercised in patients with sodium or fluid depletion as there is a risk of hypotension; blood pressure and symptoms should be carefully monitored before and during treatment. If there is hyperkalemia or if concomitant medications that may increase potassium levels are being taken, potassium levels should be frequently checked. Special attention is required for patients with renal artery stenosis, kidney transplant recipients, those with a history of angioedema, and patients after heart failure or myocardial infarction. Due to its blood pressure-lowering effects, this medication may cause side effects such as dizziness, headache, hypotension, edema, and cough; consult a doctor immediately if any unusual symptoms occur. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other blood pressure medications, potassium supplements, diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs), so all current medications should be disclosed to a doctor or pharmacist. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid its use. Safety and efficacy have not been established for children under 18 years of age, so its use is not recommended in this population. Elderly patients can take the same dose as adults, but careful observation for symptoms or side effects is necessary. In the case of overdose, severe hypotension, dizziness, or increased heart rate may occur, so immediate medical attention should be sought.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, dependent edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photophenomenon, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination difficulties, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome, pruritus, peripheral edema, hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It’s important to maintain the storage temperature between 1 to 30 degrees Celsius. This helps to ensure the medication's efficacy and safety.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

28 tablets (14 tablets/Alu-Alu pack ×2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.